Evidence for such an autoregulatory loop was found in ITP patients responding to TPO-RAs, who not only had increased platelet counts but also correlating higher TGF-β plasma levels (175). This evidence concerns the gene TGFB1 and autoimmune thrombocytopenic purpura.